Literature DB >> 9591509

Estradiol and progesterone regulate the proliferation of human breast epithelial cells.

J M Foidart1, C Colin, X Denoo, J Desreux, A Béliard, S Fournier, B de Lignières.   

Abstract

OBJECTIVE: To study the effects of estradiol and progesterone on the proliferation of normal human breast epithelial cells in vivo.
DESIGN: Double-blind randomized study.
SETTING: Departments of gynecology and of cell biology at a university hospital. PATIENT(S): Forty postmenopausal women with untreated menopause and documented plasma FSH levels of >30 mIU/mL and estradiol levels of <20 pg/mL. INTERVENTION(S): Daily topical application to both breasts of a gel containing a placebo, estradiol, progesterone, or a combination of estradiol and progesterone during the 14 days preceding esthetic breast surgery or excision of a benign lesion. MAIN OUTCOME MEASURE(S): Plasma and breast tissue concentrations of estradiol and progesterone. Epithelial cell cycles were evaluated in normal breast tissue by counting mitoses and performing quantitative proliferating cell nuclear antigen immunolabeling analyses. RESULT(S): Increasing the estradiol concentration enhanced the number of cycling epithelial cells, whereas increasing the progesterone concentration significantly limited the number of cycling epithelial cells. CONCLUSION(S): Exposure to progesterone for 14 days reduced the estradiol-induced proliferation of normal breast epithelial cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9591509     DOI: 10.1016/s0015-0282(98)00042-9

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  17 in total

1.  Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone: inhibition of cell growth and induction of apoptosis.

Authors:  B Formby; T S Wiley
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

Review 2.  Estrogens in the breast tissue: a systematic review.

Authors:  Lusine Yaghjyan; Graham A Colditz
Journal:  Cancer Causes Control       Date:  2011-02-01       Impact factor: 2.506

Review 3.  Vitamin D and mammographic breast density: a systematic review.

Authors:  Lusine Yaghjyan; Graham A Colditz; Bettina Drake
Journal:  Cancer Causes Control       Date:  2011-10-08       Impact factor: 2.506

Review 4.  Deciphering the divergent roles of progestogens in breast cancer.

Authors:  Jason S Carroll; Theresa E Hickey; Gerard A Tarulli; Michael Williams; Wayne D Tilley
Journal:  Nat Rev Cancer       Date:  2016-11-25       Impact factor: 60.716

5.  Comparison of hormone-induced mRNA and protein biomarker expression changes in breast cancer cells.

Authors:  Sarah M Bernhardt; Pallave Dasari; Danielle J Glynn; Amanda R Townsend; Timothy J Price; Wendy V Ingman
Journal:  Breast Cancer Res Treat       Date:  2021-05-31       Impact factor: 4.872

Review 6.  Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.

Authors:  Carlo Campagnoli; Françoise Clavel-Chapelon; Rudolf Kaaks; Clementina Peris; Franco Berrino
Journal:  J Steroid Biochem Mol Biol       Date:  2005-07       Impact factor: 4.292

7.  GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast.

Authors:  Eric R Prossnitz; Helen J Hathaway; Allison L Scaling
Journal:  Horm Cancer       Date:  2014-04-10       Impact factor: 3.869

8.  Progesterone in Peri- and Postmenopause: A Review.

Authors:  P-A Regidor
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-11       Impact factor: 2.915

9.  Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.

Authors:  Agnès Fournier; Alban Fabre; Sylvie Mesrine; Marie-Christine Boutron-Ruault; Franco Berrino; Françoise Clavel-Chapelon
Journal:  J Clin Oncol       Date:  2008-03-10       Impact factor: 44.544

10.  Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort.

Authors:  L Yaghjyan; M C Mahoney; P Succop; R Wones; J Buckholz; S M Pinney
Journal:  Br J Cancer       Date:  2012-01-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.